Oral corticosteroid therapy and present disease status in myasthenia gravis.

The aim of this study was to elucidate the effectiveness of oral prednisolone (PSL) according to dosing regimen in 472 patients with myasthenia gravis (MG).
We compared the clinical characteristics and PSL treatment between 226 patients who achieved minimal manifestations (MM) or better and 246 patients who remained improved (I) or worsened, according to the MG Foundation of America postintervention status.
Achievement of MM or better at peak PSL dose (odds ratio 12.25, P < 0.0001) and combined use of plasma exchange/plasmapheresis (PE/PP) and/or intravenous immunoglobulin (IVIg) (odds ratio 1.92, P = 0.04) were associated positively, and total PSL dose during the past year (odds ratio 0.17, P = 0.03) was associated negatively with present MM or better status.
Higher PSL dose and longer PSL treatment do not ensure better outcome. In the absence of a good response, the PSL dose should be decreased by combining with modalities such as PE/PP or IVIg.
AuthorsTomihiro Imai, Shigeaki Suzuki, Emiko Tsuda, Yuriko Nagane, Hiroyuki Murai, Masayuki Masuda, Shingo Konno, Yasushi Suzuki, Shunya Nakane, Kazuo Fujihara, Norihiro Suzuki, Kimiaki Utsugisawa
JournalMuscle & nerve (Muscle Nerve) Vol. 51 Issue 5 Pg. 692-6 (May 2015) ISSN: 1097-4598 [Electronic] United States
PMID25155615 (Publication Type: Journal Article, Multicenter Study)
Copyright© 2014 Wiley Periodicals, Inc.
Chemical References
  • Adrenal Cortex Hormones
  • Immunoglobulins, Intravenous
  • Prednisolone
  • Administration, Oral
  • Adolescent
  • Adrenal Cortex Hormones (administration & dosage, therapeutic use)
  • Adult
  • Aged
  • Aged, 80 and over
  • Combined Modality Therapy
  • Cross-Sectional Studies
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Immunoglobulins, Intravenous (therapeutic use)
  • Japan
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Myasthenia Gravis (diagnosis, drug therapy)
  • Plasma Exchange
  • Prednisolone (administration & dosage, therapeutic use)
  • Regression Analysis
  • Severity of Illness Index
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: